Back

Low-CRP infective endocarditis: description of a particular entity

27 August 2018 (15:50 - 16:40)
Organised by:
Congress Presentation Part of: Diagnostic progress in endocarditis Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Sophie Ribeyrolles

Montsouris Mutualist Institute, Paris (France)

6 More presentations in this session

Presentation thumbnail
Effects of coagulase reaction on aggregation in patients with endocarditis
Mr R. M'Pembele (Duesseldorf, DE)
Abstract Slides
Presentation thumbnail
Incidence of infective endocarditis in patients considered at moderate risk
Doctor L. Ostergaard (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Re-classification improvement using 18F-FDG PET CT in the diagnosis of infective endocarditis over the modified duke's criteria
Doctor C. Primus (London, GB)
Abstract
Presentation thumbnail
The real diagnostic accuracy of 18F-FDG PET/CT in patients with suspected cardiac implantable electronic device infective endocarditis: a meta-analysis
Doctor C. Olmos (Madrid, ES)
Abstract Slides
Presentation thumbnail
Usefulness of 18F-FDG PET/CT in patients with suspected cardiac implantable electronic device infection: differences between pocket infection and infective endocarditis
Doctor C. Olmos (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Diagnostic progress in endocarditis

The Event

Event poster

ESC Congress 2018

27 August 2018 15:50 CET
You may be interested in
thumbnail
Congress Presentation
Evaluating C-reactive protein-to-lymphocyte ratio: is there room for another biomarker in infective endocarditis?
19 May 2025
thumbnail
Congress Presentation
Contemporary issues of etiological diagnostic of infective endocarditis
29 June 2021
thumbnail
Webinar
Maximising multimodality imaging for patients with endocarditis
24 January 2024
thumbnail
Congress Presentation
Characteristics of patients with nonbacterial thrombotic endocarditis and factors associated with occurrence of embolic events and prognosis
21 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources